secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2022-03-11T23:59:59+00:00
Accession:  0001213900-22-011857
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma shareholders approve reverse stock split of 1-for-5 to 1-for-50
---------------------------------------------------------------------------

- Shareholders granted Board discretion to effect a reverse split at a ratio between 1:5 and 1:50.
- Reverse split must be completed by February 8, 2023.
- Vote totals: 53,847,792 in favor, 11,915 against, 240 abstain.
- Quorum of 53,859,947 shares represented at the special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390022011857/0001213900-22-011857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390022011857/ea156769-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-011857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer